16
March

Production Strategies Shift Toward “Multi-Origin”

Category: News

In March 2026, medical device manufacturers increasingly adopted multi-origin sourcing strategies to mitigate geopolitical, tariff, and logistics risks.

This includes:

  • Partial relocation of production from China to India and Southeast Asia
  • Dual or multi-sourcing of critical components

The shift is driven by growing supply chain vulnerability and global trade pressures, as medical devices rely on components sourced across multiple regions and tiers.

https://www.medworldadvisors.com/blog/tariffs-and-the-medtech-industry-disruption-realignment-and-strategic-consequences


oui décor